- Advanced Micro Devices : Benchmark at Buy with $100 Price Target
- AstraZeneca: Kepler Cheuvreux has a Buy rating. The target price is set at 9000 versus 9200 GBp.
- Best Buy : R5 Capital raises PT to $118 from $110, maintains Hold rating
- Beyond Meat: Credit Suisse lifts PT to $123 from $120, stays Neutral
- Bodycote: Jefferies remains long with target raised from GBp920 to GBp1000.
- Dollar General : JPMorgan adjusts PT to $260 from $250, maintains Overweight rating
- GAP : JPMorgan changes PT to $39 From $37, keeps Overweight rating
- Johnson & Johnson : Morgan Stanley at Overweight with $187 Price Target
- Medtronic : Oppenheimer raises PT to $147 From $134, maintains Outperform rating
- Royal Bank of Canada : BMO Capital changes PT to C$139 From C$131, maintains Market Perform rating
- Ulta Beauty : Goldman Sachs lifts PT to $399 from $348, maintains Buy rating
- Valneva: Guggenheim starts tracking the ADR as Buy with a USD 35 target.